about
Cell-scaffold interactions in the bone tissue engineering triadLocal delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs.Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering.A sugar-based phase-transitioning delivery system for bone tissue engineering.Effect of collagen-glycosaminoglycan scaffold pore size on matrix mineralization and cellular behavior in different cell types.Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents.Nanoscale chemical interaction enhances the physical properties of bioglass composites.A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates.Crosslinking and mechanical properties significantly influence cell attachment, proliferation, and migration within collagen glycosaminoglycan scaffolds.Local co-delivery of rhBMP-2 and cathepsin K inhibitor L006235 in poly(d,l-lactide-co-glycolide) nanospheres.Understanding the effect of mean pore size on cell activity in collagen-glycosaminoglycan scaffoldsThe effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering.Activated protein C (APC) can increase bone anabolism via a protease-activated receptor (PAR)1/2 dependent mechanism.Mesenchymal stem cell fate is regulated by the composition and mechanical properties of collagen-glycosaminoglycan scaffolds.Novel Freeze-Drying Methods to Produce a Range of Collagen–Glycosaminoglycan Scaffolds with Tailored Mean Pore SizesThe healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructsPTH(1-34) Treatment Increases Bisphosphonate Turnover in Fracture Repair in Rats
P50
Q26823763-7F41CAA6-115D-4DEA-8994-0AA4CCF4E635Q33808678-5A729B44-33DD-4C0B-9DFC-F179A4683C63Q36347762-DECF0782-5969-4BD8-9851-C311CC935B71Q38311762-6AF24AD8-96D6-4B14-8B0D-AB9CCAA170BFQ38834130-801A3CA1-E47D-483B-A0C3-864BC7382157Q39027910-8772E2B8-A6A2-42D2-8024-380739319C9CQ39100845-08DDE09E-E7EE-4E07-82C3-B0E83F547BA2Q39265694-C95C4848-2D22-4634-9268-258CD82F0AEAQ39620430-A8D51819-7654-41B7-8EBC-B5FE76E8C8FCQ40468691-3A15A3F4-4482-4972-89DE-4A02030B2DA3Q42407384-264074F3-A5D9-4935-A2C7-69F6E913DA48Q42833111-06B5E66A-2FD1-48B1-BB50-BBD6AEF9AE4CQ45073367-0816C03E-E752-4C9E-9490-D3930CA0310CQ50495894-BFEDCA5C-70C1-4428-9D62-C02BBFBA1D3BQ57879765-432188C1-3814-44AC-8C47-4BE830178C58Q57879805-B5C275E6-C6F6-482E-B03E-9181C9E3B8D2Q95614818-16C830C8-C9F5-4306-BD5C-F3EA7CAC881F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ciara M Murphy
@ast
Ciara M Murphy
@en
Ciara M Murphy
@es
Ciara M Murphy
@nl
type
label
Ciara M Murphy
@ast
Ciara M Murphy
@en
Ciara M Murphy
@es
Ciara M Murphy
@nl
prefLabel
Ciara M Murphy
@ast
Ciara M Murphy
@en
Ciara M Murphy
@es
Ciara M Murphy
@nl
P106
P21
P31
P496
0000-0002-9653-5477